Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Drug Delivery CDM Companies, Key Developments with Latest Offerings 2026

Date : 17 February 2026

Who are the Drug Delivery CDMO Market Top Vendors and What are Their Offerings?

Drug Delivery CDMO Market Companies

Company Overview

Companies Headquarters Drug Delivery CDMO Services
Lonza Group AG Basel, Switzerland High-potency OSD, jet milling, and spray-dried dispersions
Catalent, Inc. Somerset, U.S. Softgel innovation, modified release technologies, and large-scale lipid-based delivery
Thermo Fisher Scientific Waltham, U.S. End-to-end oral solid dosage, next-gen on-body delivery systems, and sterile injectables
Samsung Biologics Incheon, South Korea Offers industrial-scale biologics
WuXi AppTec/WuXi Biologics Shanghai, China Integrated discovery-to-manufacturing services
Recipharm AB Stockholm, Sweden High-potency API manufacturing, smart device integration, and pulmonary delivery
Siegfried Holding AG Zofingen, Switzerland Offers ophthalmic and nasal delivery systems
Boehringer Ingelheim Ingelheim am Rhein, Germany Specialized high-volume fill finish services
Kindeva Drug Delivery Woodbury, U.S. Offers expertise for complex combination development
Piramal Pharma Solutions Mumbai, India High-potency API services, integrated sterile injectable manufacturing, and cancer drug delivery

Market Growth

The drug delivery CDMO market is experiencing significant expansion, with projections indicating a revenue increase reaching several hundred million dollars by the end of the forecast period, spanning 2026 to 2035. This growth is driven by emerging trends and strong demand across key sectors.

Recent Developments in the Drug Delivery CDMO Market

  • In February 2026, Avery Pharmaceuticals Pvt. Ltd. announced its participation in the Vitafoods India 2026, where it will exhibit its cutting-edge solutions in drug delivery, contract manufacturing development services for orally dissolving strips, and engage the technical and commercial team with the attendees.
  • In January 2026, with an aim to expand the suite of integrated solutions, the AI-powered software for high-throughput salt and co-crystal screening will be developed and launched by Eurofins CDMO Alphora.

Your Drug Delivery CDMO Market insights, organized in one powerful dashboard: Access Now

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales